WAY
Waystar Holding Corp.
$22.27
-0.90
(-3.88%)
Mkt Cap
4.27B
Volume
2,202,482
52W Range
17.26-41.47
Sector
Technology
Beta
0.07
EPS (TTM)
0.70
P/E Ratio
31.81
Revenue (TTM)
1.16B
Rev Growth (5Y)
+17.4%
EPS Growth (5Y)
N/A
AlphaVal · Fair Value
What we estimate one share is worth
$40.28
Undervalued
strong signal
44.7% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.
Company Description
Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive system offers a suite of functionalities, including pre-approving finances, supporting patients with billing, overseeing claims and payments, actively preventing and recovering denied claims, enhancing revenue capture, and providing insightful analytics and reporting. The company's main clientele operates within the healthcare sector. Established in 2017, Waystar Holding Corp. is headquartered in Lehi, Utah.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 1.10B | 943.55M | 791.01M | 704.87M | 578.57M |
| Net Income | 112.09M | (19.12M) | (51.33M) | (51.45M) | (47.12M) |
| EPS | 0.63 | -0.13 | -0.31 | -0.31 | -0.28 |
| Free Cash Flow | 283.19M | 142.50M | 29.94M | 85.20M | 91.86M |
| FCF / Share | 1.48 | 0.95 | 0.18 | 0.51 | 0.55 |
| Operating CF | 309.67M | 169.77M | 51.46M | 102.63M | 106.41M |
| Total Assets | 5.95B | 4.58B | 4.58B | 4.69B | 4.78B |
| Total Debt | 1.50B | 1.26B | 2.25B | 2.26B | 2.30B |
| Cash & Equiv | 61.35M | 182.13M | 35.58M | 64.56M | 47.25M |
| Book Value | 3.88B | 3.08B | 2.05B | 2.11B | 2.12B |
| Return on Equity | 0.03 | -0.01 | -0.03 | -0.02 | -0.02 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 313.87M | 303.54M | 268.65M | 270.65M | 256.44M | 244.10M | 240.11M | 234.54M | 224.79M | 206.69M | 197.26M | 195.97M |
| Net Income | 43.28M | 19.99M | 30.65M | 32.18M | 29.27M | 19.08M | 5.41M | (27.68M) | (15.93M) | (14.41M) | (15.49M) | (10.81M) |
| EPS | 0.23 | 0.10 | 0.18 | 0.19 | 0.17 | 0.11 | 0.03 | -0.17 | -0.10 | -0.09 | -0.09 | -0.06 |
| Free Cash Flow | 69.59M | 57.22M | 76.15M | 90.99M | 58.82M | 58.55M | 70.20M | 8.58M | 5.17M | 5.67M | (16.69M) | 28.88M |
| FCF / Share | 0.36 | 0.30 | 0.44 | 0.52 | 0.34 | 0.34 | 0.41 | 0.05 | 0.03 | 0.03 | -0.10 | 0.17 |
| Operating CF | 84.91M | 66.63M | 82.03M | 96.76M | 64.25M | 64.77M | 78.82M | 15.45M | 10.73M | 11.46M | (10.45M) | 33.59M |
| Total Assets | 5.84B | 5.95B | 4.75B | 4.68B | 4.62B | 4.58B | 4.54B | 4.57B | 4.58B | 4.58B | 4.61B | 4.66B |
| Total Debt | 1.49B | 1.50B | 1.27B | 1.26B | 1.26B | 1.26B | 1.27B | 1.38B | 2.28B | 2.25B | 2.25B | 2.26B |
| Cash & Equiv | 34.34M | 76.81M | 445.36M | 290.30M | 224.00M | 182.13M | 127.12M | 68.38M | 57.34M | 35.58M | 52.85M | 95.74M |
| Book Value | 3.94B | 3.88B | 3.22B | 3.17B | 3.13B | 3.08B | 3.05B | 2.95B | 2.04B | 2.05B | 2.08B | 2.10B |
| Return on Equity | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
WAY News
Kaskela Law LLC Announces Investigation of Waystar Holding Corp. (WAY) and Encourages Long-Term WAY Shareholders to Contact the Firm
Waystar to Report Second Quarter 2026 Financial Results on July 29, 2026
Strength Seen in Waystar (WAY): Can Its 9.5% Jump Turn into More Strength?
Waystar to Host Investor Day at Waystar True North™ Conference on August 25, 2026
Waystar: Silently Taking Over Healthcare Billing
New Research Reveals Healthcare Leaders Who Unite Financial and Clinical Data Recover Millions in Previously Missed Revenue
Baron Discovery Fund Q1 2026: Who Moved The Needle
TBRG vs. Waystar: Which Healthcare RCM Stock Is the Better Bet Now?
Waystar to Speak at William Blair Conference
AI Is Coming for Pharmacy Benefit Managers: Potential Winners and Losers